How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,599 results for

Blood Pressure Control after Cerebrovascular Accident

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Blood Pressure Control after Cerebrovascular Accident

Blood Pressure Control after Cerebrovascular Accident Blood Pressure Control after Cerebrovascular Accident Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse (...) Cancer Administration 4 Blood Pressure Control after Cerebrovascular Accident Blood Pressure Control after Cerebrovascular Accident Aka: Blood Pressure Control after Cerebrovascular Accident , Stroke Related Blood Pressure Management , CVA Blood Pressure Control From Related Chapters II. Precautions management described here is for ischemic only (e.g. ) targets a lower Avoid lowering too low in acute CVA Lower correlates with lower perfusion Hypothesized that in chronic , the brain acclimatizes

2018 FP Notebook

2. Blood Pressure Control after Cerebrovascular Accident

Blood Pressure Control after Cerebrovascular Accident Blood Pressure Control after Cerebrovascular Accident Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse (...) Cancer Administration 4 Blood Pressure Control after Cerebrovascular Accident Blood Pressure Control after Cerebrovascular Accident Aka: Blood Pressure Control after Cerebrovascular Accident , Stroke Related Blood Pressure Management , CVA Blood Pressure Control From Related Chapters II. Precautions management described here is for ischemic only (e.g. ) targets a lower Avoid lowering too low in acute CVA Lower correlates with lower perfusion Hypothesized that in chronic , the brain acclimatizes

2015 FP Notebook

3. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

; alcohol intake; ambulatory care; antihypertensive: agents, drug, medication, therapy; beta adrenergic blockers; blood pressure: arterial, control, determination, devices, goal, high, improve, measurement, monitoring, ambulatory; calcium channel blockers; diet; diuretic agent; drug therapy; heart failure: diastolic, systolic; hypertension: white coat, masked, ambulatory, isolated ambulatory, isolated clinic, diagnosis, reverse white coat, prevention, therapy, treatment, control; intervention; lifestyle (...) in children and adolescents NHLBI 2004 Statements Salt sensitivity of blood pressure AHA 2016 Cardiovascular team-based care and the role of advanced practice providers ACC 2015 Treatment of hypertension in patients with coronary artery disease AHA/ACC/ASH 2015 Ambulatory blood pressure monitoring in children and adolescents AHA 2014 An effective approach to high blood pressure control AHA/ACC/CDC 2014 Ambulatory blood pressure monitoring ESH 2013 Performance measures for adults with coronary artery

2017 American Heart Association

4. Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection

Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection (RAID) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03001739 Recruitment Status : Recruiting First Posted : December 23, 2016 Last

2016 Clinical Trials

5. Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You (...) have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02357615

2015 Clinical Trials

6. Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic Hepatectomy

infusion of nitroglycerin will be used to reduce CVP. Maintaining arterial systolic blood pressure (SBP) > 90 mmHg, urine output more than 1ml/kg/h, and CVP was continuously monitored. Arterial pressure, pulse oxygen saturation ( SPO2), PaCO2 and electrocardiogram (II and V5 leads) were continuously monitored by radial artery cannulation. CVP will Returned to normal level (6 ~ 12 cmH2O) after resection to observe the wound if active bleeding still exist. Intraoperative hepatic blood flow blocking (...) Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic Hepatectomy Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic Hepatectomy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2018 Clinical Trials

7. Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.

Detailed Description: The prognostic value of central systolic/diastolic pressure, central pulse pressure and AI has been well demonstrated, firstly after CAFÉ study, with 2073 hypertensive subjects followed up 3.4 years. It also evidenced higher prognostic value of central blood pressure compared to peripheral blood pressure. One year later, the STRONG study, showed central pulse pressure to be an independent cardiovascular risk factor as well as higher prognostic value compared to peripheral pulse (...) of the study drug should be skipped for that day and keep on taking the study drug on the following day before the first meal. Other Name: Glimepiride Outcome Measures Go to Primary Outcome Measures : Effect of dapagliflozin relative to glimepiride at 24 weeks of treatment period regarding central systolic blood pressure [ Time Frame: 24 weeks ] To assess the effect of dapagliflozin relative to glimepiride at 24 weeks of treatment period in subjects with T2DM, with inadequate glycemic control regarding

2016 Clinical Trials

8. Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

will be measured by ambulatory blood pressure Blood pressure control [ Time Frame: Two months and six months ] Proportion of patients who achieve BP control (defined as clinic BP < 140/90 mmHg) after 6 months Response to study medications [ Time Frame: Two months and six months ] Proportion of "responders" (defined as clinic BP reduction > 20mmHg SBP and >10 mmHg DBP) from randomisation to 6 months Change in values of micro- and macro-albuminuria [ Time Frame: Six months ] Change in micro- and macro (...) [ Time Frame: six months ] Change in 24 hour ambulatory diastolic blood pressure between randomisation and 6 months Clinic systolic and diastolic blood pressure [ Time Frame: Six months ] Change in clinic systolic and diastolic blood pressure will be difference in values between randomisation and 6 months Night time and day time blood pressure [ Time Frame: Six months ] Change in daytime and night time blood pressure Blood pressure control [ Time Frame: Six months ] change in BP variability measured

2016 Clinical Trials

9. The Effect of Remote Ischemic Preconditioning (RIPC) on Blood Pressure and Its Vascular Protection Effect

a nonpharmacologic therapy for primary hypertension stage I until now, and there is no prospective, randomized, controlled, single-blind clinic trial to investigate the effect of RIPC on blood pressure and its vascular protection effect. The investigators hypothesize that RIPC may lower both SBP and DBP, and it improves vascular function in Chinese healthy young adults and subjects with primary hypertension stage I. To address these assumptions, the present study is designed to study the effect of RIPC on blood (...) to right upper limb and repeat the procedure described above. Change back to left upper limb and repeat the same procedure. Perform once a day ( Thus 15 minutes a day). Outcome Measures Go to Primary Outcome Measures : Change from Baseline in Systolic Blood Pressure at 1 month [ Time Frame: Baseline; 1 week after RIPC; 1 month after RIPC ] systolic pressure lowers 6mmHg Change from Baseline in Diastolic Blood Pressure at 1 month [ Time Frame: Baseline; 1 week after RIPC; 1 month after RIPC ] diastolic

2015 Clinical Trials

10. Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

) appear to be at increased risk of both hypertensive disorders of pregnancy and gestational diabetes. In the non-pregnant population, OSA is typically treated with continuous positive airway pressure (CPAP) during sleep and has been shown to reduce blood pressure in hypertensive patients. Unfortunately, data on whether maternal and neonatal outcomes could be improved with treatment of OSA during pregnancy are extremely limited. This study aims to address this knowledge gap. A randomized controlled (...) onset heart failure with ejection fraction (EF) < 40% Cerebrovascular accident Myocardial infarction New onset atrial fibrillation Fetal or Neonatal Death [ Time Frame: through 72 hours postpartum ] Antepartum, intrapartum, or neonatal death Neonatal respiratory support [ Time Frame: within 72 hours of delivery ] Intubation, continuous positive airway pressure (CPAP) or high-flow nasal cannula (HFNC) for ventilation or cardiopulmonary resuscitation Birth weight [ Time Frame: Immediately post birth

2018 Clinical Trials

11. A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

provided by (Responsible Party): Takeda Study Details Study Description Go to Brief Summary: The purpose of this study is to evaluate the efficacy and safety of the fixed dose combinations of azilsartan medoxomil plus chlorthalidone (40/12.5 and 40/25 mg), once daily, in participants with grades 2 or 3 essential hypertension who do not reach target blood pressure following treatment with 40 mg azilsartan medoxomil monotherapy after 4 weeks. Condition or disease Intervention/treatment Phase Essential (...) Hypertension Drug: Azilsartan medoxomil/placebo Drug: Azilsartan medoxomil - chlorthalidone Phase 3 Detailed Description: Eligible participants completed a 2-week single-blind run-in period (Days -42 to -29) prior to a Single-Blind Monotherapy Treatment Period (Day -28 to Day -1) where they received azilsartan medoxomil 40 mg. After the Single-Blind Monotherapy Treatment Period, those participants who achieved target blood pressure discontinued treatment and resumed standard of care management

2011 Clinical Trials

12. Blunt Cerebrovascular Injury

to blunt trauma. AJNR Am J Neuroradiol . 1983;4:292–295. Fakhry SM, Jaques PF, Proctor HJ. Cervical vessel injury after blunt trauma. J Vasc Surg . 1988;8:501–508. Ahmad HA, Gerraty RP, Davis SM, Cameron PA. Cervicocerebral artery dissections. J Accid Emerg Med . 1999;16:422–424. Berne JD, Norwood SH, McAuley CE, Vallina VL, Creath RG, McLarty J. The high morbidity of blunt cerebrovascular injury in an unscreened population: more evidence of the need for mandatory screening protocols. J Am Coll Surg (...) , GA 31404; email: brombwi1@memorialhealth.com. Scope of the Problem Blunt injury to the carotid or vertebral vessels (blunt cerebrovascular injury [BCVI]) is diagnosed in approximately 1 of 1,000 (0.1%) patients hospitalized for trauma in the United States unless a screening program has been initiated. [1] However, the majority of these injuries are diagnosed after the development of symptoms secondary to central nervous system ischemia, with a resultant neurologic morbidity of up to 80

2010 Eastern Association for the Surgery of Trauma

13. Manual exchange blood transfusion protocol

(if >2.5kg) of blood are removed every five to 10 minutes, via the other line. SVET over one to two hours dependent on stability of patient. Monitor pulse, blood pressure, oxygen saturations and respiratory rate throughout the procedure. Inspect toes, feet and buttocks for signs of circulatory compromise, if using umbilical arterial or venous catheter. After procedure, recheck FBC and Hct, and ensure ongoing adequate hydration ( ). Pertussis In severe pertussis infection in infants under 90 days of age (...) and/or cryoprecipitate ( ). Necrotising enterocolitis (NEC). Rapid withdrawal of blood from a umbilical venous catheter (UVC) induces negative pressure that may be transmitted to mesenteric veins, which may contribute to NEC. Inform Blood Transfusion Laboratory if any reaction to a blood transfusion occurs (ext 8527) or out of hours bleep the biomedical scientist on call (bleep 0590). Process for exchange transfusion Preliminary investigations FBC, blood group, antibody screen and crossmatch, HbS% (HbS percentage

2014 Publication 1593

14. Manual exchange blood transfusion protocol

(if >2.5kg) of blood are removed every five to 10 minutes, via the other line. SVET over one to two hours dependent on stability of patient. Monitor pulse, blood pressure, oxygen saturations and respiratory rate throughout the procedure. Inspect toes, feet and buttocks for signs of circulatory compromise, if using umbilical arterial or venous catheter. After procedure, recheck FBC and Hct, and ensure ongoing adequate hydration ( ). Pertussis In severe pertussis infection in infants under 90 days of age (...) and/or cryoprecipitate ( ). Necrotising enterocolitis (NEC). Rapid withdrawal of blood from a umbilical venous catheter (UVC) induces negative pressure that may be transmitted to mesenteric veins, which may contribute to NEC. Inform Blood Transfusion Laboratory if any reaction to a blood transfusion occurs (ext 8527) or out of hours bleep the biomedical scientist on call (bleep 0590). Process for exchange transfusion Preliminary investigations FBC, blood group, antibody screen and crossmatch, HbS% (HbS percentage

2014 Publication 1593

15. Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions

surgery prior to randomization. Subject with history of cerebrovascular accident (including ischemic, embolic, and hemorrhagic cerebrovascular accident), transient ischemic attack, deep venous thrombosis (DVT; including proximal and distal), pulmonary or arterial embolism, arterial thrombosis or other venous thrombosis within 6 months prior to randomization Note: prior superficial thrombophlebitis is not an exclusion criterion. New-onset seizures or poorly controlled seizures within 12 weeks prior (...) for: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: Experimental Arm: luspatercept (ACE-536) 1.0 mg/kg subcutaneous (SC) every 3 weeks (Q3W) Drug: Luspatercept Luspatercept Active Comparator: Control Arm: epoetin alfa 450 IU/kg subcutaneous (SC) weekly Drug: Epoetin alfa Epoetin alfa Other Name: EPREX® / PROCRIT® Outcome Measures Go to Primary Outcome Measures : Red Blood Cell Transfusion Independence (RBCTI) for 24 weeks [ Time Frame: Randomization through Week 24

2018 Clinical Trials

16. Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive

Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Prevention Official Title: A Randomized, Double-Blind, Placebo Control Trial Comparing Effects and Safety of TAURINE GRANULE and Placebo on Blood Pressure in Prehypertensive. Study Start Date : December 2012 Actual Primary Completion Date : March 2015 Actual Study Completion Date : March 2015 Resource links provided by the National Library (...) Outcome Measures : The decrease in blood pressure after an 12-week oral Taurine granule administration. [ Time Frame: 12 weeks ] Evaluate the effects of Taurine granule on blood pressure and metabolic parameters in prehypertensive patients after an 12-week oral administration. Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join

2013 Clinical Trials

17. Is the Excess Cardiovascular Morbidity in Pheochromocytoma Related to Blood Pressure or to Catecholamines? (PubMed)

Is the Excess Cardiovascular Morbidity in Pheochromocytoma Related to Blood Pressure or to Catecholamines? It is generally accepted that pheochromocytoma is associated with an increased cardiovascular risk. This is however not based on studies with an appropriate control group of patients with essential hypertension.We examined whether patients with pheochromocytoma have an excess cardiovascular morbidity as compared to hypertensive patients.In a retrospective case-control study we reviewed (...) the medical charts of 109 pheochromocytoma patients for cardiovascular events within 5 years prior to the diagnosis. These patients were matched to control patients with essential hypertension for gender and year of birth and diagnosis. Outcome variables were ischemic heart disease, cerebrovascular accidents, and transient ischemic attacks. Classical cardiovascular risk factors were also assessed.A significantly higher rate of patients with pheochromocytoma suffered a cardiovascular event (13.8%; 95

Full Text available with Trip Pro

2013 Journal of Clinical Endocrinology and Metabolism

18. Transfusion Using Stored Whole Blood

blood pressure <100, as well as adult male patients with systolic blood pressure <100 during periods when whole blood is not available, will receive component therapy (1:1:1 packed red blood cells: plasma:platelets) for transfusion. Outcome Measures Go to Primary Outcome Measures : Volume of blood products transfused during resuscitation [ Time Frame: From admission to 24 hours after admission ] Volume of blood products transfused (whole blood, packed red blood cells, platelets, and plasma) within (...) Study Description Go to Brief Summary: Massive hemorrhage is a major cause of potentially preventable death following trauma. A common consequence of hemorrhagic shock is uncontrollable bleeding from coagulopathy, leading to death from exsanguination. Even when bleeding is controlled, patients are at increased risk of complications and mortality. Reconstituted whole blood, or component therapy with packed red blood cells (PRBCs), plasma, and platelets was introduced by the military in recent

2016 Clinical Trials

19. Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients

Eligible for Study: 35 Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Blood pressure: 120mmHg≤SBP<160mmHg, and/or 80mmHg≤DBP<100mmHg Exclusion Criteria: Diabetes Hypertension: SBP≥160mmHg, or DBP≥100mmHg known allergy to trial drugs Myocardial infarction or cerebrovascular accident in the year preceding the trial Clinical Congestive Heart Failure Secondary hypertension Pregnancy or lactating women Malignant tumor (...) : A Randomized, Double-Blind, Placebo Control Trial Comparing Effects and Safety of DANSHU Capsule(Menthol) and Placebo on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients Study Start Date : August 2012 Estimated Primary Completion Date : September 2018 Estimated Study Completion Date : October 2018 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator

2011 Clinical Trials

20. Effect of Febuxostat on Blood Pressure

Trial) Actual Enrollment : 121 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension Study Start Date : February 2012 Actual Primary Completion Date : August (...) and night. The 24-hour mean is the average of all measurements recorded for 24 hours after dosing. Secondary Outcome Measures : Change From Baseline in 24-hour Mean Diastolic Blood Pressure (DBP) Measured by Ambulatory Blood Pressure Monitoring at Week 6 [ Time Frame: Baseline and Week 6 ] The change in 24-hour mean DBP measured at final visit or Week 6 relative to baseline. Ambulatory blood pressure monitoring measures blood pressure at regular intervals throughout the day and night. The 24-hour mean

2011 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>